NYSEARCA:HAO

Haoxi Health Technology (HAO) Price, Holdings, & News

$7.93
-0.06 (-0.75%)
(As of 01:33 PM ET)
Today's Range
$7.72
$8.81
50-Day Range
$4.40
$8.91
52-Week Range
$4.03
$10.60
Volume
214,794 shs
Average Volume
74,539 shs
Market Capitalization
$15.86 million
Assets Under Management
$50.43 million
Dividend Yield
8.83%
Net Expense Ratio
0.75%

About Haoxi Health Technology

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, which include online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help its advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video platforms and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.

HAO Stock Price History

HAO ETF News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Health Tech: UNH surprise beat
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Health care goes high-tech
See More Headlines
Receive HAO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haoxi Health Technology and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Fund Name
Invesco China Small Cap ETF
Tax Classification
Current Symbol
NYSEARCA:HAO
Inception Date
1/1/2100
Fund Manager
N/A

Fund Focus

Asset Class
Benchmark
N/A
Category
Focus
Development Level
Region
Number of Holdings
0

Fund Statistics

Assets Under Management
$50.43 million
Average Daily Volume
$20,928.60
Discount/Premium
-0.08%

Administrator, Advisor and Custodian

Administrator
N/A
Advisor
N/A
Custodian
N/A
Distributor
N/A
Transfer Agent
N/A
Trustee
N/A
Lead Market Maker
N/A

Miscellaneous

Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Haoxi Health Technology Expenses

TypeHAONYSEARCA ETFsAll ETFs
Management Fee0.55%0.51%0.51%
Other Expenses0.35%0.64%0.58%
Total Expense0.90%0.74%0.70%
Fee Waiver-0.15%-0.68%-0.57%
Net Expense0.75%0.58%0.58%

Haoxi Health Technology (HAO) Exposure

HAO Geographic Exposure

HAO Currency Exposure

Key Executives

  • Mr. Zhen Fan (Age 44)
    CEO & Chairman of the Board of Directors
  • Mr. Bo Lyu (Age 45)
    Chief Financial Officer
  • Mr. Lei Xu (Age 35)
    COO & Director

HAO ETF - Frequently Asked Questions

How have HAO shares performed in 2024?

Haoxi Health Technology's stock was trading at $25.13 at the beginning of 2024. Since then, HAO stock has decreased by 67.8% and is now trading at $8.08.
View the best growth stocks for 2024 here
.

What is the management fee for Haoxi Health Technology?

Haoxi Health Technology's management fee is 0.55% and has other expenses of 0.35%. However, HAO has a fee waiver of -0.15% to reimburse the expenses. The net expense ratio for HAO is 0.75%.

How do I buy shares of Haoxi Health Technology?

Shares of HAO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:HAO) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners